The estimated Net Worth of Charles W Patrick is at least $1.47 Million dollars as of 27 August 2018. Charles Patrick owns over 8,000 units of Orasure Technologies stock worth over $230,767 and over the last 19 years Charles sold OSUR stock worth over $1,237,904.
Charles has made over 10 trades of the Orasure Technologies stock since 2016, according to the Form 4 filled with the SEC. Most recently Charles sold 8,000 units of OSUR stock worth $130,320 on 27 August 2018.
The largest trade Charles's ever made was selling 29,883 units of Orasure Technologies stock on 27 February 2017 worth over $337,379. On average, Charles trades about 4,639 units every 24 days since 2006. As of 27 August 2018 Charles still owns at least 54,298 units of Orasure Technologies stock.
You can see the complete history of Charles Patrick stock trades at the bottom of the page.
Charles's mailing address filed with the SEC is 220 EAST FIRST STREET, , BETHLEHEM, PA, 18015.
Over the last 21 years, insiders at Orasure Technologies have traded over $21,897,384 worth of Orasure Technologies stock and bought 196,200 units worth $1,037,188 . The most active insiders traders include Douglas A Michels, Ronald H Spair, and Michael J Gausling. On average, Orasure Technologies executives and independent directors trade stock every 43 days with the average trade being worth of $221,123. The most recent stock trade was executed by Kathleen Gallagher Weber on 19 December 2023, trading 24,129 units of OSUR stock currently worth $194,238.
based in bethlehem, pennsylvania, orasure technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. these products include tests for the detection of antibodies to the hiv virus, including the oraquick® in-home hiv test, oraquick advance® rapid hiv-1/2 antibody test and the orasure® hiv-1 oral specimen collection device, a test for antibodies to the hcv virus, the oraquick® hcv rapid antibody test, and oral fluid testing solutions for drugs of abuse testing, including intercept® oral fluid drug testing system and q.e.d.® saliva alcohol test. orasure also manufactures and sells several leading cryosurgical products. these include: histofreezer®, a product for the cryosurgical removal of common and plantar warts and several other benign skin lesions, sold to the professional or physician office market, as well as an over-the-counter product fo
Orasure Technologies executives and other stock owners filed with the SEC include: